These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10029600)

  • 1. TEL/PDGFbetaR induces hematologic malignancies in mice that respond to a specific tyrosine kinase inhibitor.
    Tomasson MH; Williams IR; Hasserjian R; Udomsakdi C; McGrath SM; Schwaller J; Druker B; Gilliland DG
    Blood; 1999 Mar; 93(5):1707-14. PubMed ID: 10029600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal myeloproliferation, induced in mice by TEL/PDGFbetaR expression, depends on PDGFbetaR tyrosines 579/581.
    Tomasson MH; Sternberg DW; Williams IR; Carroll M; Cain D; Aster JC; Ilaria RL; Van Etten RA; Gilliland DG
    J Clin Invest; 2000 Feb; 105(4):423-32. PubMed ID: 10683371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TEL/PDGFbetaR fusion protein activates STAT1 and STAT5: a common mechanism for transformation by tyrosine kinase fusion proteins.
    Wilbanks AM; Mahajan S; Frank DA; Druker BJ; Gilliland DG; Carroll M
    Exp Hematol; 2000 May; 28(5):584-93. PubMed ID: 10812249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways.
    Carroll M; Tomasson MH; Barker GF; Golub TR; Gilliland DG
    Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14845-50. PubMed ID: 8962143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a role of NF-kappaB in the survival of hematopoietic cells mediated by interleukin 3 and the oncogenic TEL/platelet-derived growth factor receptor beta fusion protein.
    Besançon F; Atfi A; Gespach C; Cayre YE; Bourgeade MF
    Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8081-6. PubMed ID: 9653143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The TEL/PDGFbetaR fusion in chronic myelomonocytic leukemia signals through STAT5-dependent and STAT5-independent pathways.
    Sternberg DW; Tomasson MH; Carroll M; Curley DP; Barker G; Caprio M; Wilbanks A; Kazlauskas A; Gilliland DG
    Blood; 2001 Dec; 98(12):3390-7. PubMed ID: 11719379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusion of Huntingtin interacting protein 1 to platelet-derived growth factor beta receptor (PDGFbetaR) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2).
    Ross TS; Bernard OA; Berger R; Gilliland DG
    Blood; 1998 Jun; 91(12):4419-26. PubMed ID: 9616134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins.
    Carroll M; Ohno-Jones S; Tamura S; Buchdunger E; Zimmermann J; Lydon NB; Gilliland DG; Druker BJ
    Blood; 1997 Dec; 90(12):4947-52. PubMed ID: 9389713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation.
    Golub TR; Barker GF; Lovett M; Gilliland DG
    Cell; 1994 Apr; 77(2):307-16. PubMed ID: 8168137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ARG tyrosine kinase activity is inhibited by STI571.
    Okuda K; Weisberg E; Gilliland DG; Griffin JD
    Blood; 2001 Apr; 97(8):2440-8. PubMed ID: 11290609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The coupling of TEL/PDGFbetaR to distinct functional responses is modulated by the presence of cytokine: involvement of mitogen-activated protein kinases.
    Wheadon H; Welham MJ
    Blood; 2003 Aug; 102(4):1480-9. PubMed ID: 12714513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Tel-PDGFRbeta fusion gene produces a chronic myeloproliferative syndrome in transgenic mice.
    Ritchie KA; Aprikyan AA; Bowen-Pope DF; Norby-Slycord CJ; Conyers S; Bartelmez S; Sitnicka EH; Hickstein DD
    Leukemia; 1999 Nov; 13(11):1790-803. PubMed ID: 10557054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming properties of the Huntingtin interacting protein 1/ platelet-derived growth factor beta receptor fusion protein.
    Ross TS; Gilliland DG
    J Biol Chem; 1999 Aug; 274(32):22328-36. PubMed ID: 10428802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells.
    Lacronique V; Boureux A; Monni R; Dumon S; Mauchauffé M; Mayeux P; Gouilleux F; Berger R; Gisselbrecht S; Ghysdael J; Bernard OA
    Blood; 2000 Mar; 95(6):2076-83. PubMed ID: 10706877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rabaptin-5 is a novel fusion partner to platelet-derived growth factor beta receptor in chronic myelomonocytic leukemia.
    Magnusson MK; Meade KE; Brown KE; Arthur DC; Krueger LA; Barrett AJ; Dunbar CE
    Blood; 2001 Oct; 98(8):2518-25. PubMed ID: 11588050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stable expression of small interfering RNA sensitizes TEL-PDGFbetaR to inhibition with imatinib or rapamycin.
    Chen J; Wall NR; Kocher K; Duclos N; Fabbro D; Neuberg D; Griffin JD; Shi Y; Gilliland DG
    J Clin Invest; 2004 Jun; 113(12):1784-91. PubMed ID: 15199413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloproliferative disease induced by TEL-PDGFRB displays dynamic range sensitivity to Stat5 gene dosage.
    Cain JA; Xiang Z; O'Neal J; Kreisel F; Colson A; Luo H; Hennighausen L; Tomasson MH
    Blood; 2007 May; 109(9):3906-14. PubMed ID: 17218386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusion of H4/D10S170 to the platelet-derived growth factor receptor beta in BCR-ABL-negative myeloproliferative disorders with a t(5;10)(q33;q21).
    Kulkarni S; Heath C; Parker S; Chase A; Iqbal S; Pocock CF; Kaeda J; Cwynarski K; Goldman JM; Cross NC
    Cancer Res; 2000 Jul; 60(13):3592-8. PubMed ID: 10910073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TEL gene is involved in myelodysplastic syndromes with either the typical t(5;12)(q33;p13) translocation or its variant t(10;12)(q24;p13).
    Wlodarska I; Mecucci C; Marynen P; Guo C; Franckx D; La Starza R; Aventin A; Bosly A; Martelli MF; Cassiman JJ
    Blood; 1995 May; 85(10):2848-52. PubMed ID: 7742547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MN1-TEL fusion protein, encoded by the translocation (12;22)(p13;q11) in myeloid leukemia, is a transcription factor with transforming activity.
    Buijs A; van Rompaey L; Molijn AC; Davis JN; Vertegaal AC; Potter MD; Adams C; van Baal S; Zwarthoff EC; Roussel MF; Grosveld GC
    Mol Cell Biol; 2000 Dec; 20(24):9281-93. PubMed ID: 11094079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.